MFAP5 was an independent predictor of survival in advanced ovarian cancer, and could promote tumor proliferation and endothelial cell motility through αβV3 integrin mediated signaling, providing a potential mechanistic link between MFAP5 and angiogenesis as well as patient survival [22, 23]. This evidence concerns the gene MFAP5 and neoplasm.